Basic Information
RNALocate ID: | RLID:11000862 |
RNA Symbol: | hsa-miR-26b-5p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-26b |
RNA ID: | miRBase:MIMAT0000083 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 20976003 |
Tissue/Cell Line: | Breast cancer cell line (MCF-7) |
Method: | Microarray |
Description: | Because of the suggested roles of extracellular miRNAs in signaling and diagnosis, we investigated whether the intracellular and extracellular miRNA composition are the same. To answer this question, we performed microRNA microarray analyses of MCF7 cellular (c) and extracellular (x) RNAs (Figure 2A), and found that about 66% of the released miRNAs are at an abundance that closely reflects the cellular miRNA abundance (Figures 2B and 2C). This finding is in agreement with a model wherein most, but not all miRNAs are released passively by mass action. Data are collected from Figure 2. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01001357 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001358 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:01001359 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001360 | Nucleus | Colon adenocarcinoma cells | 20864815 |
RLID:11000861 | Exosome | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
RLID:11000863 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
RLID:11000864 | Exosome | Renal cancer cells | 21670082 |
RLID:11000865 | Exosome | Breast milk | 22211110 |
RLID:11000866 | Exosome | Brain tissue | 23382797 |
RLID:11000867 | Exosome | Plasma | 23663360 |
RLID:11000868 | Extracellular vesicle | HEK-293T cells | 22849433 |
RLID:11000869 | Microvesicle | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
RLID:11000870 | Microvesicle | Plasma | 23077538 |
RLID:11000871 | Microvesicle | Seminal plasma | 23539611 |
RLID-D:11000019 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Lymphoma tissue|Mast cells|Seminal fluid|Tongue tissue | |
RLID-D:11000282 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-26b-5p | Diffuse large b cell lymphoma | MNDR-E-MI-33339 |
MNDR | hsa-miR-26b-5p | Splenic marginal zone lymphoma | MNDR-E-MI-33340 |
MNDR | hsa-miR-26b-5p | Oral squamous cell carcinoma | MNDR-E-MI-33341 |
MNDR | hsa-miR-26b-5p | Large cell neuroendocrine cancer | MNDR-E-MI-33342 |
MNDR | hsa-miR-26b-5p | Medulloblastoma | MNDR-E-MI-33343 |
MNDR | hsa-miR-26b-5p | B cell lymphoma of malt type | MNDR-E-MI-33344 |
MNDR | hsa-miR-26b-5p | Ovarian clear cell carcinoma | MNDR-E-MI-33345 |
MNDR | hsa-miR-26b-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-33346 |
MNDR | hsa-miR-26b-5p | Lymphoma | MNDR-E-MI-33347 |
MNDR | hsa-miR-26b-5p | Lymphoma non-hodgkin | MNDR-E-MI-33348 |
MNDR | hsa-miR-26b-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-33349 |
MNDR | hsa-miR-26b-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-33350 |
MNDR | hsa-miR-26b-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-33351 |
MNDR | hsa-miR-26b-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-33352 |
MNDR | hsa-miR-26b-5p | Breast cancer luminal | MNDR-E-MI-33353 |
MNDR | hsa-miR-26b-5p | Niemann-pick disease type c | MNDR-E-MI-33354 |
MNDR | hsa-miR-26b-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-33355 |
MNDR | hsa-miR-26b-5p | B cell acute lymphoblastic leukemia | MNDR-E-MI-33356 |
MNDR | hsa-miR-26b-5p | Dermatomyositis | MNDR-E-MI-33357 |
MNDR | hsa-miR-26b-5p | Prostate cancer | MNDR-E-MI-33358 |
MNDR | hsa-miR-26b-5p | Gastric cancer | MNDR-E-MI-33359 |
MNDR | hsa-miR-26b-5p | Gastric lymphoma | MNDR-E-MI-33360 |
MNDR | hsa-miR-26b-5p | Alzheimer disease | MNDR-E-MI-33361 |
MNDR | hsa-miR-26b-5p | Intracranial aneurysm | MNDR-E-MI-33362 |
MNDR | hsa-miR-26b-5p | Urinary bladder cancer | MNDR-E-MI-33363 |
MNDR | hsa-miR-26b-5p | Esophageal carcinoma | MNDR-E-MI-33364 |
MNDR | hsa-miR-26b-5p | Dysautonomia familial | MNDR-E-MI-33365 |
MNDR | hsa-miR-26b-5p | Head and neck cancer | MNDR-E-MI-33366 |
MNDR | hsa-miR-26b-5p | Lewy body dementia | MNDR-E-MI-33367 |
MNDR | hsa-miR-26b-5p | Leukemia | MNDR-E-MI-33368 |
MNDR | hsa-miR-26b-5p | Cardiovascular disease | MNDR-E-MI-33369 |
MNDR | hsa-miR-26b-5p | Lung cancer | MNDR-E-MI-33370 |
MNDR | hsa-miR-26b-5p | Parkinson disease | MNDR-E-MI-33371 |
MNDR | hsa-miR-26b-5p | Niemann-pick disease | MNDR-E-MI-33372 |
MNDR | hsa-miR-26b-5p | Breast cancer | MNDR-E-MI-33373 |
MNDR | hsa-miR-26b-5p | Pituitary neoplasms | MNDR-E-MI-33374 |
MNDR | hsa-miR-26b-5p | Pancreatic cancer | MNDR-E-MI-33375 |
MNDR | hsa-miR-26b-5p | Melanoma | MNDR-E-MI-33376 |
MNDR | hsa-miR-26b-5p | Rectum adenocarcinoma | MNDR-E-MI-33377 |
MNDR | hsa-miR-26b-5p | Nephroblastoma | MNDR-E-MI-33378 |
MNDR | hsa-miR-26b-5p | Colon cancer | MNDR-E-MI-33379 |
MNDR | hsa-miR-26b-5p | Colon adenocarcinoma | MNDR-E-MI-33380 |
MNDR | hsa-miR-26b-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-33381 |
MNDR | hsa-miR-26b-5p | Ovarian cancer | MNDR-E-MI-33382 |
MNDR | hsa-miR-26b-5p | Prostate adenocarcinoma | MNDR-E-MI-33383 |
MNDR | hsa-miR-26b-5p | Laryngeal carcinoma | MNDR-E-MI-33384 |
MNDR | hsa-miR-26b-5p | Kidney cancer | MNDR-E-MI-33385 |
MNDR | hsa-miR-26b-5p | Glioblastoma | MNDR-E-MI-33386 |
MNDR | hsa-miR-26b-5p | Glioma | MNDR-E-MI-33387 |
MNDR | hsa-miR-26b-5p | Oligodendroglioma | MNDR-E-MI-33388 |
MNDR | hsa-miR-26b-5p | Central nervous system lymphoma | MNDR-E-MI-33389 |
MNDR | hsa-miR-26b-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-33390 |
MNDR | hsa-miR-26b-5p | Epilepsy temporal lobe | MNDR-E-MI-33391 |
MNDR | hsa-miR-26b-5p | Osteosarcoma | MNDR-E-MI-33392 |
MNDR | hsa-miR-26b-5p | Inclusion body myositis | MNDR-E-MI-33393 |
MNDR | hsa-miR-26b-5p | Meningioma | MNDR-E-MI-33394 |
MNDR | hsa-miR-26b-5p | Liver cancer | MNDR-E-MI-33395 |
MNDR | hsa-miR-26b-5p | Cervical adenocarcinoma | MNDR-E-MI-33396 |
MNDR | hsa-miR-26b-5p | Gastric adenocarcinoma | MNDR-E-MI-33397 |
MNDR | hsa-miR-26b-5p | Cervical squamous cell carcinoma | MNDR-E-MI-33398 |
MNDR | hsa-miR-26b-5p | Pituitary adenoma | MNDR-E-MI-33399 |
MNDR | hsa-miR-26b-5p | Lung squamous cell carcinoma | MNDR-E-MI-33400 |
MNDR | hsa-miR-26b-5p | Non-small cell lung adenocarcinoma | MNDR-E-MI-33401 |
MNDR | hsa-miR-26b-5p | Lung adenocarcinoma | MNDR-E-MI-33402 |
MNDR | hsa-miR-26b-5p | Thyroid carcinoma | MNDR-E-MI-33403 |
MNDR | hsa-miR-26b-5p | Ovarian carcinoma | MNDR-E-MI-33404 |
MNDR | hsa-miR-26b-5p | Carcinoma renal cell | MNDR-E-MI-33405 |
MNDR | hsa-miR-26b-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-33406 |
MNDR | hsa-miR-26b-5p | Renal clear cell carcinoma | MNDR-E-MI-33407 |
MNDR | hsa-miR-26b-5p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-33408 |
MNDR | hsa-miR-26b-5p | Cholangiocarcinoma | MNDR-E-MI-33409 |
MNDR | hsa-miR-26b-5p | Lung small cell carcinoma | MNDR-E-MI-33410 |
MNDR | hsa-miR-26b-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-33411 |
MNDR | hsa-miR-26b-5p | T acute lymphoblastic leukemia | MNDR-E-MI-33412 |
MNDR | hsa-miR-26b-5p | Acute t cell leukemia | MNDR-E-MI-33413 |
MNDR | hsa-miR-26b-5p | Acute heart failure | MNDR-E-MI-33414 |
MNDR | hsa-miR-26b-5p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-33415 |
MNDR | hsa-miR-26b-5p | Early hepatocellular carcinoma | MNDR-E-MI-33416 |
MNDR | hsa-miR-26b-5p | B-cell lymphoma | MNDR-E-MI-33417 |
MNDR | hsa-miR-26b-5p | Rheumatoid arthritis | MNDR-E-MI-33418 |
MNDR | hsa-miR-26b-5p | T-cell leukemia | MNDR-E-MI-33419 |
MNDR | hsa-miR-26b-5p | Neuroblastoma | MNDR-E-MI-33420 |
MNDR | hsa-miR-26b-5p | Barrett's adenocarcinoma | MNDR-E-MI-33421 |
MNDR | hsa-miR-26b-5p | Osteoarthritis | MNDR-E-MI-33422 |
MNDR | hsa-miR-26b-5p | Hodgkin lymphoma | MNDR-E-MI-33423 |
MNDR | hsa-miR-26b-5p | Ulcerative colitis | MNDR-E-MI-33424 |
MNDR | hsa-miR-26b-5p | Burkitt lymphoma | MNDR-E-MI-33425 |
MNDR | hsa-miR-26b-5p | Dementia vascular | MNDR-E-MI-33426 |
MNDR | hsa-miR-26b-5p | Psoriasis | MNDR-E-MI-33427 |
MNDR | hsa-miR-26b-5p | Acute myelocytic leukemia | MNDR-E-MI-33428 |
MNDR | hsa-miR-26b-5p | Colorectal cancer | MNDR-E-MI-33429 |
MNDR | hsa-miR-26b-5p | Nasopharynx carcinoma | MNDR-E-MI-33430 |
MNDR | hsa-miR-26b-5p | Multiple myeloma | MNDR-E-MI-33431 |
MNDR | hsa-miR-26b-5p | Acute lymphocytic leukemia | MNDR-E-MI-33432 |
MNDR | hsa-miR-26b-5p | Ovarian epithelial cancer | MNDR-E-MI-33433 |
MNDR | hsa-miR-26b-5p | Cardiomegaly | MNDR-E-MI-33434 |
MNDR | hsa-miR-26b-5p | Nasopharyngeal cancer | MNDR-E-MI-33435 |
MNDR | hsa-miR-26b-5p | Stroke lacunar | MNDR-E-MI-33436 |
MNDR | hsa-miR-26b-5p | Barrett's carcinogenesis | MNDR-E-MI-33437 |
MNDR | hsa-miR-26b-5p | Breast cancer her3+ negative | MNDR-E-MI-33438 |
MNDR | hsa-miR-26b-5p | High grade dysplastic nodule | MNDR-E-MI-33439 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ABCA1 | Homo sapiens | RR00022108 |
TOP